Prescriptions: Lilly Halts Alzheimer's Drug Trial
New York Times Article
By ANDREW POLLACK
Published: August 17, 2010
In yet another setback in efforts to treat Alzheimer’s disease, Eli Lilly & Company announced on Tuesday that it had halted development of an experimental treatment after the compound actually made patients worse in two late-stage clinical trials.
Conversation Clips with Dr. David Geldmacher
|
Concern About Memory Loss |
Reducing Risk |
Advancements |
Where are we with biomarker diagnosis and other tests for Alzheimer's Disease?
Watch Steven T. DeKosky, MD discuss testing issues in the following short video clips.
Copyright © 2011 by the Rector and Visitors of the University of Virginia
Office of Continuing Medical Education
P.O. Box 800711 Charlottesville, VA 22908
phone 434–924–5310 | fax 434–982–1415
Programming and Development by
